Monday, November 26, 2018

FDA puts Zafgen's diabetes trial on hold

Zafgen Inc said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on the investigational new drug application for a trial of its experimental diabetes drug.


from Reuters: Health News https://ift.tt/2ReB7jD
via IFTTT

0 comments:

Post a Comment